Is Catabasis Pharmaceuticals, Inc. (CATB) a Buy, Sell, or Hold?
NASDAQ : CATB
Catabasis Pharmaceuticals, Inc.
$8.54 USD
-$0.64 (-6.97%)
- Volume
- 98.87K
- Average Volume
- 528.92K
- Market Capitalization
- $234.86M
- P/E Ratio
- -5.02
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.26
- Year Low
- $1.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.78
CATB vs. The Competition
| Properties | CATB | CBLI | CELU | CRGX |
|---|---|---|---|---|
| Market Cap | $234.86M | $226.39M | $18.76M | $216.19M |
| Shares Outstanding | $27.5M | $71.42M | $24.05M | $48.36M |
| P/E Ratio | -5.02 | -16.68 | -0.21 | -1.59 |
| EPS | 0 | -0.19 | -3.58 | -2.79 |
| Day Low | 8.48 | 3.11 | 0.78 | 4.47 |
| Day high | 9.21 | 3.5 | 0.7954 | 4.47 |
| Year Low | 1.25 | 2.7 | 0.56 | 3 |
| Year High | 10.26 | 5.64 | 4.35 | 25.45 |
| Average Price 50 | 8.228566 | 3.5693333 | 0.80578 | 4.4484 |
| Average Price 200 | 3.7395024 | 3.5693333 | 1.32598 | 7.80745 |
| Volume | 98872 | 116.26K | 23376 | 9.53M |
| Average Volume | - | - | - | - |